Roche
2023
The pharmaceutical industry is one of Germany’s most important export industries. In recent years, the export of pharmaceutical products has seen above-average growth compared to the other export sectors. In addition, research and development play a prominent role for pharmaceutical companies.
Our new study for Roche focuses on these two aspects. It examines the extent to which the German pharmaceutical industry is particularly value-added intensive and innovative in its exports.
Compared to those in the other industries, German pharmaceutical exports are characterised by above-average value-added intensity and growth dynamics. This means that the export of pharmaceutical products (for example, worth one million euros) is linked to more domestic value added and jobs than the average German export of one million euros.
In an international comparison, the German pharmaceutical industry is shown to be one of the most important players on the world market and has been able to maintain its share of world exports in recent years.
In terms of research, the German pharmaceutical industry is losing ground on its international competitors:
For this detailed investigation of the German pharmaceutical industry in a national and international comparison, we relied on the available statistical data. This was then analysed with the help of the Prognos model landscape.
To the study (PDF in German)
Further information, in German (Roche website)
Project team: Dr Georg Klose, Dr Andreas Sachs, Johann Weiss
Latest update: 07.12.2023
Senior Project Manager
With green finance, greenhouse gases in Austria can be reduced by up to four per cent by 2040 – in the bond market alone. This is the result of our study commissioned by the Ministry for Climate Action.
Prognos supports the Citizens' Advisory Council in incorporating the perspectives of the population into decision-making processes and advises the responsible staff unit of the State Chancellery.
German industry is dependent on raw materials and preliminary products from abroad. On behalf of the Netzwerk Zukunft der Industrie e. V., Prognos analyses the supply chains and provides recommendations for action.
The green economy is a driving force in North Rhine-Westphalia. Both gross value added and the number of people in employment are increasing at a faster rate than in other sectors of the economy.
The automotive industry is undergoing fundamental change. How does this effect employment? And what will it mean for the individual professions? We investigated this on behalf of the VDA.
On behalf of the Federal Ministry for the Environment, Prognos compiled the Green Tech Atlas 2025. The atlas provides a comprehensive overview of the cross-sectional environmental tech-nology and resource efficiency industries.
On behalf of the Federal Ministry of Education, Science and Research and the Federal Government Commissioner for Culture and the Media, Prognos and partner analysed the economic and social situation of self-employed solo artists in creative professions.
A shrinking workforce, digitalisation and decarbonisation: Prognos examines the specific effects of global trends on regional labour markets.
Higher numbers of care-dependent persons and increasing costs - our aging population is putting long-term care insurance to the test. A new analysis shows what the future financial require-ments will be.
How effectively do the federal states utilise ERDF funding? Prognos supports various federal states with the evaluation of their ERDF programmes.
Prognos is one of the oldest economic research centres in Europe. Founded at the University of Basel, Prognos experts have been conducting research for a wide range of clients from the public and private sectors since 1959 – politically independent, scientifically sound.